NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/09/2025
Voltar para busca
Dado oficial do USPTO
ABZENA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ABZENA
ST13
US500000086234440Classe
1, 5, 42, 44
Pedido
86234440
Registro
4737716
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
10/09/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42, 44
Data de depósito
27/03/2014
Data de registro
19/05/2015
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/09/2025
Última transação
10/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
24
Localização do titular
CAMBRIDGE, GB
Examinador
LOTT, MAUREEN
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
ABZENA (UK) LIMITED
PolyTherics Ltd.
Representantes
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in manufacturing pharmaceuticals; Chemical preparations for use in the manufacture of pharmaceuticals; Chemicals for use in the pharmaceutical industry; chemicals for use in the pharmaceutical industryintermediates for pharmaceuticals; intermediates being chemicals for use in industrychemicals for use in the manufacture of pharmaceuticals
Classe 5
Pharmaceuticalspharmaceutical compositionspharmaceutical preparationsused to treat cancerdiseases of the immune systemviral infectionsHIVInfluenzainflammatory diseasesfibrotic diseasespulmonary diseasesblood disordersneurodegenerative diseasesgraft rejection; chemical preparations for medical or pharmaceutical purposeschemicals sold as integral component parts of pharmaceutical preparations for the treatment of cancerdiseases of the immune systemviral infectionsHIVInfluenzainflammatory diseasesfibrotic diseasespulmonary diseasesblood disordersneurodegenerative diseasesgraft rejection; chemico-pharmaceutical preparationspharmaceutical preparations for the treatment of cancerdiseases of the immune systemviral infectionsHIVInfluenzainflammatory diseasesfibrotic diseasespulmonary diseasesblood disordersneurodegenerative diseasesgraft rejection
Classe 42
Scientific research and product development services in relation to pharmaceutical and medical products; scientific servicesproduct development in the field of pharmaceuticals; researchscientific research and product development in the field of pharmaceuticals; industrial research in the field of pharmaceuticals; product design in the field of pharmaceuticals; Pharmaceutical research services; Pharmaceutical product evaluation; Testing of pharmaceuticals; Pharmaceutical drug development services; Development of pharmaceutical preparations and medicines; Providing medical and scientific research information in the field of pharmaceuticals; provision of scientific information in the fields of cancerdiseases of the immune systemviral infectionsHIVInfluenzainflammatory diseasesfibrotic diseasespulmonary diseasesblood disordersneurodegenerative diseasesgraft rejection; providing of scientific information regarding pharmaceuticals and medicines; provision of scientific information relating to the chemical industryinformation on the subject of chemical product development
Classe 44
Medical servicesproviding medical information regarding pharmaceuticals; pharmaceutical services and provision of pharmaceutical informationall in the nature of providing medical information regarding pharmaceuticals; providing to others a collection of informationproviding medical information relating to the use of pharmaceuticals
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/09/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/09/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/09/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
09/05/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
19/05/2024
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
21/09/2021
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
21/09/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
21/09/2021
ES8R
TEAS SECTION 8 RECEIVED
18/05/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
19/05/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
31/07/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/04/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
19/05/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/03/2015
PUBO
PUBLISHED FOR OPPOSITION
03/03/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/02/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
23/01/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/01/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
22/01/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
22/01/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
22/01/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
22/01/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/01/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/01/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/01/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
15/12/2014
GNRT
NON-FINAL ACTION E-MAILED
15/12/2014
CNRT
NON-FINAL ACTION WRITTEN
15/12/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/11/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/11/2014
ALIE
ASSIGNED TO LIE
24/11/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/11/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
28/06/2014
GNRT
NON-FINAL ACTION E-MAILED
28/06/2014
CNRT
NON-FINAL ACTION WRITTEN
28/06/2014
DOCK
ASSIGNED TO EXAMINER
28/06/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/04/2014
NWAP
NEW APPLICATION ENTERED
31/03/2014
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ABZENA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.